Virios Therapeutics, Inc. (VIRI)
NASDAQ: VIRI · IEX Real-Time Price · USD
0.440
-0.013 (-2.87%)
At close: May 1, 2024, 4:00 PM
0.431
-0.009 (-1.95%)
After-hours: May 1, 2024, 7:40 PM EDT

Virios Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Net Income
-5.3-12.25-15.96-10.35-2.47-2.11
Share-Based Compensation
0.620.580.327.4300
Other Operating Activities
-0.190.2-0.05-0.980.380.92
Operating Cash Flow
-4.87-11.47-15.69-3.9-2.09-1.2
Share Issuance / Repurchase
1.164.49-0.131.5300
Debt Issued / Paid
0001.932.370
Other Financing Activities
----0.08-1.15
Financing Cash Flow
1.164.49-0.133.382.371.15
Net Cash Flow
-3.71-6.98-15.7929.490.28-0.05
Free Cash Flow
-4.87-11.47-15.69-3.9-2.09-1.2
Free Cash Flow Per Share
-0.26-1.04-1.88-0.79-0.43-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).